Antitubercular Drug Development: Current Status and Research Strategies

Author(s): Kuldipsinh P. Barot, Stoyanka Nikolova, Illiyan Ivanov, Manjunath D. Ghate.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 13 , Issue 11 , 2013

Become EABM
Become Reviewer

Abstract:

Recent developments and novel research strategies are adopted widely to discover and develop the new drugs to treat tuberculosis. New antitubercular drugs are urgently needed because tuberculosis remains a global health problem as around nine million new cases are estimated each year with almost two million fatalities. It states the impact and outcomes that have made a significant effect in antitubercular drug development. We are presenting current status of tuberculosis, antitubercular drug development, novel molecular targets, novel agents in clinical and pre-clinical development and some efforts that are being made in the development of novel molecules based on different pharmacophores as lead compounds and recent strategies.

Keywords: Tuberculosis, molecular targets, novel agents in evaluation phase, novel antitubercular agents, novel heterocyclic molecules.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 11
Year: 2013
Page: [1664 - 1684]
Pages: 21
DOI: 10.2174/13895575113139990076
Price: $58

Article Metrics

PDF: 10